Document:

EX-10.5

Exhibit 10.5

[Execution Copy]

AMENDMENT TO CONFIRMATION

     THIS AMENDMENT (this “Amendment”) is made as of September 15, 2008, among Merrill Lynch
International (“Dealer”), Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Agent”) and Mylan
Inc. (“Issuer”).

     WHEREAS, Dealer, Agent and Issuer are parties to a Confirmation dated as of September 9, 2008
(the “Confirmation”) evidencing an OTC Warrant Transaction (Ref. No. 088593443);

     WHEREAS, the parties wish to amend the Confirmation on the terms and conditions set forth in
this Amendment;

     NOW, THEREFORE, in consideration of their mutual covenants herein contained, the parties
hereto agree as follows:

     Section 1. Terms Used but Not Defined Herein. Terms used but not defined herein shall have
the respective meanings given to them in the Confirmation.

     Section 2. Amendment to the Confirmation.

	 	(a)	 	The “Premium” under the Confirmation shall be USD43,792,000.
	 
	 	(b)	 	The “Number of Warrants” shall be 30,217,728.

     Section 3. Representations and Warranties.

     Issuer represents and warrants to Dealer as follows:

	 	(a)	 	On the date of this Amendment, (A) none of Issuer or any of its officers and
directors is aware of any material nonpublic information regarding Issuer or the
Shares and (B) all reports and other documents filed by Issuer with the Securities and
Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), when considered as a whole (with the more recent such reports and
documents deemed to amend inconsistent statements contained in any earlier such
reports and documents), do not contain any untrue statement of a material fact or any
omission of a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances in which they were made, not
misleading.
	 
	 	(b)	 	Issuer is not entering into this Amendment to create actual or apparent
trading activity in the Shares (or any security convertible into or exchangeable for
Shares) or to raise or depress or otherwise manipulate the price of the Shares (or any
security convertible into or exchangeable for Shares) or otherwise in violation of the
Exchange Act.
	 
	 	(c)	 	The representations and warranties of Issuer set forth in Section 3 of the
Agreement and in Confirmation opposite the caption “Compliance with Securities Laws”
are true and correct and are hereby deemed to be repeated to Dealer as if set forth
herein.

     Section 4. Effectiveness. This Amendment shall become effective upon execution by the parties
hereto.

     Section 5. Counterparts. This Amendment may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if all of the signatures thereto and hereto
were upon the same instrument.

(Mylan_MLI_Warrant_Amendment)

 

 

     Section 6. Governing Law. This Amendment shall be governed by the laws of the State of New
York (without reference to its choice of law doctrine, other than Title 14 of the New York General
Obligations Law).

     Section 7. Effectiveness of Confirmation. Except as amended hereby, all the terms of the
Confirmation shall remain and continue in full force and effect and are hereby confirmed in all
respects.

(Mylan_MLI_Warrant_Amendment)

 

 

     IN WITNESS WHEREOF, the parties have signed this Amendment as of the date and year first above
written.

	 	 	 	 	 
	 	MERRILL LYNCH INTERNATIONAL

 	 
	 	By:  	/s/
David Royce	 
	 	 	Name:  	David Royce	 
	 	 	Title:  	Authorized Signatory	 
	 

Agreed and accepted by :

	 	 	 	 	 
	MYLAN INC.

 	 	 
	By:  	/s/
Edward J. Borkowski	 	 
	 	Name:  	Edward J. Borkowski	 	 
	 	Title:  	Executive Vice President and Chief Financial Officer	 	 
	 

Acknowledged and agreed as to matters to the Agent:

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

Solely in its capacity as Agent hereunder

	 	 	 	 	 
	By:  	/s/
Fran Jacobson	 	 
	 	Name:  	Fran Jacobson	 	 
	 	Title:  	Authorized Signatory	 	 
	 

(Mylan_MLI_Warrant_Amendment)EX-10.6

Exhibit 10.6

[Execution Copy]

AMENDMENT TO CONFIRMATION

     THIS AMENDMENT (this “Amendment”) is made as of September 15, 2008, between Wells Fargo Bank,
National Association (“Dealer”) and Mylan Inc. (“Issuer”).

     WHEREAS, Dealer and Issuer are parties to a Confirmation dated as of September 9, 2008 (the
“Confirmation”) evidencing a Warrant Transaction (Ref. No. OTC091108203C);

     WHEREAS, the parties wish to amend the Confirmation on the terms and conditions set forth in this
Amendment;

     NOW, THEREFORE, in consideration of their mutual covenants herein contained, the parties hereto
agree as follows:

     Section 1. Terms Used but Not Defined Herein. Terms used but not defined herein shall have the respective
meanings given to them in the Confirmation.

     Section 2. Amendment to the Confirmation.

	 	(a)	 	The “Premium” under the Confirmation shall be USD18,768,000.
	 
	 	(b)	 	The “Number of Warrants” shall be 12,950,455.

     Section 3. Representations and Warranties.

     Issuer represents and warrants to Dealer as follows:

	 	(a)	 	On the date of this Amendment, (A) none of Issuer or any of its officers and directors is aware of
any material nonpublic information regarding Issuer or the Shares and (B) all reports and other
documents filed by Issuer with the Securities and Exchange Commission pursuant to the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), when considered as a whole (with the more
recent such reports and documents deemed to amend inconsistent statements contained in any earlier
such reports and documents), do not contain any untrue statement of a material fact or any omission
of a material fact required to be stated therein or necessary to make the statements therein, in
the light of the circumstances in which they were made, not misleading.
	 
	 	(b)	 	Issuer is not entering into this Amendment to create actual or apparent trading activity in the
Shares (or any security convertible into or exchangeable for Shares) or to raise or depress or
otherwise manipulate the price of the Shares (or any security convertible into or exchangeable for
Shares) or otherwise in violation of the Exchange Act.
	 
	 	(c)	 	The representations and warranties of Issuer set forth in Section 3 of the Agreement and in
Confirmation opposite the caption “Compliance with Securities Laws” are true and correct and are
hereby deemed to be repeated to Dealer as if set forth herein.

     Section 4. Effectiveness. This Amendment shall become effective upon execution by the parties hereto.

     Section 5. Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be
an original, with the same effect as if all of the signatures thereto and hereto were upon the same
instrument.

(WFC_Mylan_Warrant_Amendment)

 

 

     Section 6. Governing Law. This Amendment shall be governed by the laws of the State of New York (without
reference to its choice of law doctrine, other than Title 14 of the New York General Obligations
Law).

     Section 7. Effectiveness of Confirmation. Except as amended hereby, all the terms of the Confirmation shall
remain and continue in full force and effect and are hereby confirmed in all respects.

2

 

     IN WITNESS WHEREOF, the parties have signed this Amendment as of the date and year first above
written.

	 	 	 	 	 
	 	WELLS FARGO BANK, NATIONAL ASSOCIATION

 	 
	 	By:  	/s/
Gordy Holteman	 
	 	 	Name:  	Gordy Holteman	 
	 	 	Title:  	Authorized Signatory	 
	 

	 	 	 	 	 
	Confirmed as of the date first above written:

MYLAN INC.

 	 	 
	By:  	/s/
Edward J. Borkowski	 	 
	 	Name:  	Edward J. Borkowski	 	 
	 	Title:  	Executive Vice President and Chief Financial
Officer	 	 
	 

 (WFC_Mylan_Warrant_Amendment)EX-10.7

Exhibit 10.7

AMENDMENT

dated as of September 9, 2008

to the

Confirmation of OTC Warrant Transaction

dated as of March 1, 2007

between

Mylan, Inc. (formerly Mylan Laboratories Inc.),

as seller,

Merrill Lynch International,

as buyer,

and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as agent

(the “Agreement”)

The parties have previously entered into the Agreement and have now agreed to amend the Agreement
by the terms of this Amendment (this “Amendment”).

Accordingly, in consideration of the mutual agreements contained in this Amendment, the parties
agree as follows:

1. Amendment of the Agreement

The Agreement is hereby amended by replacing the first paragraph opposite the caption “Limitations
on Net Physical Settlement by Counterparty” with the following text:

“Notwithstanding anything herein or in the Agreement to the contrary, the number
of Shares that may be delivered at settlement by Counterparty shall not exceed the
product of 1.5 times the initial Number of Warrants at any time (“Maximum
Deliverable Share Amount”), as adjusted by the Calculation Agent to account
for any subdivision, stock-split, reclassification or similar dilutive event with
respect to the Shares.”

2. Representations

Each party represents to the other party in respect of the Agreement, as amended pursuant to this
Amendment, that all representations made by it pursuant to the Agreement are true and accurate as
of the date of this Amendment.

3. Miscellaneous

(a) Entire
Agreement; Restatement.

 

 

	 	(i)	 	This Amendment constitutes the entire agreement and
understanding of the parties with respect to its subject matter and supersedes
all oral communication and prior writings (except as otherwise provided
herein) with respect thereto.
	 
	 	(ii)	 	Except for any amendment to the Agreement made pursuant to
this Amendment, all terms and conditions of the Agreement will continue in
full force and effect in accordance with its provisions on the date of this
Amendment. References to the Agreement will be to the Agreement, as amended
by this Amendment.

(b) Amendments. No amendment, modification or waiver in respect of the matters contemplated by
this Amendment will be effective unless made in accordance with the terms of the Agreement.

(c) Counterparts. This Amendment may be executed and delivered in counterparts (including by
facsimile transmission), each of which will be deemed an original.

(d) Headings. The headings used in this Amendment are for convenience of reference only and are
not to affect the construction of or to be taken into consideration in interpreting this Amendment.

(e) Governing
Law. This Amendment will be governed by and construed in accordance with the laws of
the State of New York (without reference to choice of law doctrine).

 

 

IN WITNESS WHEREOF the parties have executed this Amendment on the respective dates specified below
with effect from the date specified first on the first page of this Amendment.

	 	 	 	 	 	 	 	 	 	 	 
	MYLAN INC.	 	 	 	MERRILL LYNCH INTERNATIONAL	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Brian Byala	 	 	 	By:	 	/s/ David Royce	 	 
	 

	 	 

	 	 	 	 
	 	 

	 	 
	Name:

	 	Brian Byala
	 	 	 	Name:
	 	David Royce
	 	 
	Title:

	 	Authorized Signatory	 	 	 	Title:	 	Authorized Signatory	 	 
	Date:
	 	September 9, 2008	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Acknowledged and agreed as to matters to the Agent:	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Solely in its capacity as Agent hereunder	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	By:	 	/s/ Fran Jacobson	 	 
	 

	 	 

	 	 	 	 
	 	 

	 	 
	 

	 	 	 	 	 	Name:
	 	Fran Jacobson
	 	 
	 

	 	 	 	 	 	Title:	 	VP	 	 
	 

	 	 	 	 	 	Date:	 	September 9, 2008

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]